Officials from the Centers for
Disease Control and Prevention (CDC) in USA are in talks with health officials
in Nigeria about the prospects for conducting a phase 1 safety study of the
Ebola vaccine among healthy adults in the country amid mounting anxiety about
the spread of the deadly virus in West Africa, according to the National
Institutes of Health (NIH).
The pace of human safety testing for
experimental Ebola vaccines has been expedited in response to the ongoing virus
outbreak in West Africa which has impacted negatively on businesses in the
three affected countries of Liberia, Sierra Leone and Guinea, with neighbouring
countries closing their borders and banning flights from affected countries to
other parts of Africa.
NIH explained that
